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Summary and Implications 
The objective of this study was to estimate the impact 
of a single injection of extended-release eprinomectin on 
economically relevant production variables in beef cows 
and calves as well as subsequent feedlot health, 
performance and carcass traits of calves compared to a 
traditional, short-duration anthelmintic. Animals from 13 
cooperator herds across 7 states were stratified within 
herd and assigned to 1 of 2 treatments; injectable 
doramectin (DOR) or injectable extended-release 
eprinomectin (EPR). There were no differences in pre-
weaning cow or calf performance including weight, ADG, 
reproductive success, or weaning weight. Although EPR 
cows did have a lower incidence of pinkeye, there were 
no differences in pinkeye incidence of calves. Fecal 
samples collected at the start and end of the grazing 
season indicated a greater reduction in fecal egg counts 
(FEC) for EPR cows, however, FEC at each timepoint 
were well below threshold indicative of clinical 
parasitism. When evaluating feedlot performance, EPR 
calves tended to have lower incidence of morbidity, 
however there were no differences in growth 
performance. When evaluating carcass traits, calves 
treated with EPR during the pre-weaning phase had a 
greater marbling score and a greater average quality 
grade. While there were noted improvements for EPR 
calves during the feedlot phase including improved 
morbidity and quality grade, we believe that a lack of 
parasitic infection during the grazing season may have 
resulted in a lack of performance differences in this study.   
 
Introduction 
It has been well documented that gastrointestinal 
parasites can be detrimental to cattle health and 
performance. Anthelmintic treatment has long been used 
in all sectors of the beef industry to mitigate the negative 
effects of parasitic infection. In cow-calf production, 
anthelmintic treatment has been shown to improve cow 
BW and BCS, reproductive success, and calf 
performance. The effects of anthelmintic treatment during 
the feeding phase have been shown to improve live 
performance as well as carcass characteristics. Studies 
have also linked calfhood deworming treatment to 
improved lifetime performance including growth and 
health.  
 In 2012, Merial, Inc. released the extended-
release version of their injectable anthelmintic drug, 
eprinomectin. This product label claims 100-150 days of 
parasite protection with one injection. To date, little 
research has been published regarding the effects of 
extended-release eprinomectin on cow-calf performance. 
Therefore, the objective of this study was to assess 
economically relevant performance parameters in cow 
herds following administration of extended-release 
eprinomectin at the start of the grazing season and to 
assess subsequent feedlot performance of progeny.  
 
Materials and Methods 
To study the effects of extended-release eprinomectin 
on cow-calf systems, twelve cooperator herds located in 
seven states (Iowa, Missouri, Indiana, Kentucky, 
Tennessee, Ohio, and Georgia) participated in the study. 
The total number of animals enrolled in the trial was 
1,768 cow-calf pairs and included both spring- and fall-
calving herds. Animals were stratified within herd by cow 
age, calf birth date, calf birth BW, and calf sex and 
assigned to 1 of 2 treatments; injectable doramectin 
(DOR; Dectomax™, Zoetis, Animal Health, Parsippany, 
NJ; n=879) or injectable eprinomectin (EPR; 
LongRange™, Merial, Duluth, GA; n=889). Calves were 
either treated directly through anthelmintic treatment or 
indirectly through treatment of the dam. 
Performance parameters of interest are included in 
Table 1. Cow body weights (BW) and body condition 
scores (BCS) were taken at time of treatment and again at 
the end of the trial. Calves were weighed at time of 
treatment and at weaning. Birth weights of fall calves 
were evaluated to determine if summer treatment 
impacted fetal growth.  
Fecal samples were randomly collected from a subset 
of cows at both treatment and the end of grazing to 
evaluate fecal egg count (FEC).  
Available herd health records were used to analyze 
incidence of pinkeye over the course of the grazing 
season. In July, fly counts were conducted on a subset of 
five herds to evaluate fly burden. Herds included in the 
analysis consisted of both spring- and fall-calving herds.  
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For all herds, overall breeding season pregnancy rates 
were collected for both spring and fall herds and 
conception rates to AI were evaluated where applicable. 
For all spring-calving herds, calving distribution for the 
2017 calving season as well as calving interval between 
2016 and 2017 were evaluated. 
After weaning, a subset of calves from each herd at 
the discretion of the cooperator were then sent to a Tri-
County Steer Carcass Futurity (TCSCF) feedlot for the 
finishing phase. While at TCSCF, feedlot performance 
and health were monitored. Following slaughter, carcass 
data were collected. Feedlot performance, morbidity, and 
carcass parameters were analyzed.  
Performance variables were analyzed using the 
MIXED procedure of SAS. Reproductive end points, 
health outcomes, and quality grade distribution were 
analyzed using the GLIMMIX procedure in SAS (SAS 
Inst. Inc., Cary, NC).         
 
Results and Discussion 
 Cow performance data is presented in Table 2. There 
were no differences in initial or final BW (P ≥ 0.32) as 
well as no differences in ADG or change in BW (P ≥ 
0.12) over the course of the grazing season. Subsequently, 
there were no differences in initial or final BCS (P ≥ 
0.23).  
While extended-release eprinomectin is not labeled 
for fly control, one of the objectives of the current study 
was to evaluate claims of reduced fly burden and 
incidence of pinkeye. There was no difference in fly 
burden between EPR and DOR cows (P ≥ 0.62). 
Interestingly, EPR cows tended (P = 0.06) to have a lower 
incidence of pinkeye, although this reduction is not 
explained by differences in fly burden. There was no 
difference in incidence of pinkeye between treatment 
groups for calves (P = 0.43). There has been speculation 
that the fly control associated with extended-release 
eprinomectin is correlated with the reduction in pinkeye 
within treated herds. Fly control following treatment with 
extended-release eprinomectin is believed to be a result of 
residue in manure pats that disrupt egg and larval 
development in a manner similar to an insect-growth 
regulator (IGR). Studies have shown that treatment with 
extended-release eprinomectin can reduce horn fly 
burdens in grazing stocker cattle. However, there are no 
data on its effectiveness on face flies, the main 
transmitters of pinkeye within a grazing herd. 
Additionally, face flies can travel long distances and 
spend minimal time on an animal. This makes control of 
these pests difficult with products such as IGR. Therefore, 
it is hard to identify a causal relationship between fly 
control and pinkeye with this product.  
Initial FEC were not different between treatment 
groups in this study (P = 0.89; Table 3). Final FEC were 
lower (P = 0.02) in EPR cows compared to DOR cows. 
Subsequently, EPR cows had a greater overall reduction 
in FEC compared to DOR cows (P = 0.01). However, 
FEC of both treatments at both initial and at final 
performance measurements were far below a threshold 
that would be indicative of clinical parasitism. 
Evaluation of reproductive success indicated no 
difference in conception to AI, overall breeding season 
pregnancy rates, calving distribution or calving interval (P 
≥ 0.33; Table 3). It is important to note that in the 
Midwest and Eastern Corn belt, where a large majority of 
producers on this study were located, anthelmintic 
treatment, and subsequently pasture turnout, often 
coincide with initiation of the breeding season. Therefore, 
it is unlikely that there was enough time for deworming to 
impact spring breeding season success due to altered 
plane of energy.  
Results for calf growth and performance are reported 
in Table 4. There were no differences in birth BW for 
calves regardless of tier or calving season (P = 0.57). Calf 
BW at time of treatment for calves in tier two was not 
different (P = 0.50). Likewise, weaning weights were not 
different between the two treatment groups regardless of 
tier or calving season (P = 0.75) and there was no 
difference in overall pre-weaning ADG (P = 0.57). 
Feedlot performance and carcass measurements are 
presented in Table 5. There were no differences in final 
BW or ADG during the feeding period BW (P ≥ 0.13). 
However, when evaluating health of calves in the feedlot, 
EPR calves were treated for various health issues fewer 
times compared to DOR calves (P = 0.05) indicating 
improved health status.  
Subsequent carcass measurements (Table 5) showed 
no differences due to treatment including HCW, KPH, or 
backfat (BF; P ≥ 0.22). Likewise, REA and YG were 
similar (P ≥ 0.60) between treatments. Calves treated with 
EPR had a higher marbling score as well as higher 
average quality grade (P ≤ 0.01). This resulted in 
difference in quality grade distribution where EPR calves 
have a greater percentage of carcasses grade average 
choice or higher compared to DOR (38.4% DOR; 49.7% 
EPR; P = 0.03).  
 
Conclusion 
The results of this study show no difference in cow 
performance or reproductive success over the course of 
the grazing season when comparing extended-release 
eprinomectin to a conventional, short duration 
anthelmintic. Likewise, there were no improvements in 
calf pre-weaning performance or feedlot performance.  
While carcass characteristics were largely unchanged due 
to treatment, there was an improvement in quality grade 
for EPR treated calves. Improved immunocompetency via 
extended parasite protection during the preweaning phase 
may have had long-term impacts on feedlot morbidity 
resulting in improved quality grade measurements. This 
was evidenced by a lower percent of illness during the 
feeding phase, increased marbling score, a higher average 
  
quality grade, and a higher percent of EPR calves grading 
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Table 1: Requirements for cooperator herd participation. 
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Reproduction end points 
• Conception to AI 
• Overall breeding season pregnancy rates 
• Calving distribution 2017 




Table 2: Performance of cows treated with different anthelmintic treatments during the grazing season. 
 Treatment1   
Item DOR EPR SEM P-Value3 
BW, lbs.     
   Treatment 1273 1275 25.1 0.85 
   Weaning 1283 1282 25.1 0.40 
   Change in4, lbs. 18.77 26.8 10.4 0.13 
   Change in4, % 1.95 2.67 0.81 0.12 
Performance     
   ADG4, lbs. 0.12 0.17 0.08 0.23 
BCS     
   Treatment 5.57 5.57 0.07 0.99 
   Weaning 5.58 5.60 0.09 0.59 
   Change in 0.00 0.02 0.08 0.67 
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, Parsippany); EPR = eprinomectin (LongRange; 
Merial, Duluth, GA). 
2Larger SEM presented (n = 828 DOR; n = 832 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Calculations based on weight changes from treatment to weaning/end of grazing season. 
 
  
Table 3: Health and reproductive success of cows treated with different anthelmintic treatments during the grazing 
season. 
 Treatment1   
Item DOR EPR SEM P-Value3 
FEC     
   Initial 2.07 2.97 0.49 0.18 
   Final 1.76 0.71 0.34 0.02 
   Change in  -0.30 -2.12 0.60 0.01 
Health     
   Cow Pinkeye, % 8.4 4.6 --- 0.06 
   Live Fly Counts  62 60 11.3 0.62 
   Picture Fly Counts 50 58 11.8 0.69 
Reproduction, % (no./no.)     
   Conception to AI 47 (157/334) 50 (164/327) --- 0.51 
   Pregnancy Rate4 88 (729/828) 88 (733/832) --- 0.45 
Calving Interval5, d 371 370 2.1 0.72 
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, Parsippany); EPR = eprinomectin (LongRange; 
Merial, Duluth, GA). 
2Larger SEM presented (n = 828 DOR; n = 832 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Pregnancy rate for 2016. 
5Calving interval from 2016 to 2017 calving. 
 
Table 4: Performance and health of calves who were treated with different anthelmintic treatments during the 
grazing season.  
 Treatment1   
Item DOR EPR SEM P-Value 
BW, lbs.     
   Birth 78 78 2.0 0.57 
   Treatment 314 311 16.3 0.50 
   Weaning4 452 452 17.6 0.75 
Performance, lbs.     
   Treatment ADG5 2.27 2.29 0.09 0.34 
   Weaning ADG6 2.32 2.31 0.05 0.66 
Health, %     
   Pinkeye 18.6 21.1 --- 0.43 
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, Parsippany); EPR = eprinomectin (LongRange; 
Merial, Duluth, GA). 
2Larger SEM presented (n = 828 DOR; n = 832 EPR). 
3P-value: Tendency 0.05 < P ≤ 0.10. 
4Actual weaning weight. 
5Calculation based on weight change from time of anthelmintic treatment to weaning. 









Table 5: Feedlot and carcass characteristics of calves who were treated with different, pre-weaning anthelmintic treatments. 
  
 Treatment1   
Item DOR EPR SEM2 P-Value3 
BW, lbs.     
   Initial 810 825 32.0 0.20 
   Re-Implant 974 998 24.6 0.07 
   Final 1222 1235 21.2 0.13 
Performance, lbs.     
   ADG 3.57 3.52 0.33 0.33 
Health     
   Treated, % 22.4 13.6 --- 0.05 
Carcass Quality     
   HCW5, lbs. 760 767 13.0 0.22 
   Dress6, % 61.7 61.9 0.00 0.24 
   Backfat, cm. 1.39 1.37 0.07 0.55 
   KPH7, % 2.28 2.23 0.08 0.12 
   Ribeye area8, cm.2 81.90 82.25 1.14 0.58 
   Yield grade9 2.55 2.58 0.11 0.61 
   Marbling score10 1081 1101 12.6 0.01 
   Quality grade11 12.27 12.56 0.14 <0.01 
% QG Distribution12     
   Avg choice or Higher 40.38 51.43 --- 0.03 
   Low choice 47.31 41.43 --- 0.63 
   Select and lower 12.31 7.14 --- 0.37 
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, Parsippany); EPR = eprinomectin (LongRange; Merial, 
Duluth, GA). 
2Larger SEM presented (n = 238 DOR; n = 259 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Hot carcass weight. 
5Dressing percent. 
6Kidney, pelvic, heart fat. 
7Marbling score: small: 1,0000, modest: 1,1000, moderate: 1,2000, etc. 
8USDA quality grade: 12: Choice-, 13: Choice0, 14: Choice+, etc. 
9Percentage of steers in each treatment by quality grade, within treatment total is 100%.  
 
